Cargando…

COVID-19: Clinical features and outcomes in unvaccinated 2-dose and 3-dose vaccinated against SARS-CoV-2 patients with systemic autoimmune and autoinflammatory rheumatic diseases

Clinical data on vaccinated patients with coronavirus disease 2019 (COVID-19) who have systemic autoimmune and autoinflammatory rheumatic diseases (SAARD) are limited. This observational study aimed to report the clinical features and outcomes of COVID-19 among cases with SAARD that were unvaccinate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bakasis, Athanasios-Dimitrios, Mavragani, Clio P., Voulgari, Paraskevi V., Gerolymatou, Nafsika, Argyropoulou, Ourania D., Vlachoyiannopoulos, Panayiotis G., Skopouli, Fotini N., Tzioufas, Athanasios G., Moutsopoulos, Haralampos M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181272/ https://www.ncbi.nlm.nih.gov/pubmed/35717727 http://dx.doi.org/10.1016/j.jaut.2022.102846

Ejemplares similares

COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review
por: Bakasis, Athanasios-Dimitrios, et al.
Publicado: (2021)

COVID-19 and Autoimmune/Autoinflammatory Rheumatic Disease Patients: Lessons Learned and Questions Anticipating Answers
por: Bakasis, Athanasios-Dimitrios, et al.
Publicado: (2021)

A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases
por: Tzioufas, Athanasios G., et al.
Publicado: (2021)

Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study
por: Laskari, Katerina, et al.
Publicado: (2010)

Late and booster anti‐SARS‐CoV‐2 humoral responses in nonresponder vaccinated patients with rheumatic diseases receiving mycophenolate or rituximab: comment on the article by XXX et al
por: Bakasis, Athanasios‐Dimitrios, et al.
Publicado: (2022)

Scleroderma specific autoantibodies in rheumatoid arthritis and Sjögren's syndrome patients with interstitial lung disease: Prevalence and associations
por: Koulouri, Vasiliki, et al.
Publicado: (2022)

Clinical and Laboratory Predictors of Distinct Histopathogical Features of Lupus Nephritis
por: Mavragani, Clio P., et al.
Publicado: (2015)

Primary Sjögren’s Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development
por: Goules, Andreas V., et al.
Publicado: (2020)

Predicting the Outcome of Sjogren’s Syndrome-Associated Non-Hodgkin’s Lymphoma Patients
por: Papageorgiou, Aristea, et al.
Publicado: (2015)

Hashimoto Thyroiditis, Anti-Parietal Cell Antibodies: Associations With Autoimmune Diseases and Malignancies
por: Boutzios, Georgios, et al.
Publicado: (2022)

Incidence and Prevalence of Major Central Nervous System Involvement in Systemic Lupus Erythematosus: A 3-Year Prospective Study of 370 Patients
por: Kampylafka, Eleni I., et al.
Publicado: (2013)

Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren’s Syndrome
por: Argyriou, Evangelia, et al.
Publicado: (2021)

Extensive phenotyping of vascular damage in non-infectious primary vasculitides with the use of non-invasive vascular biomarkers: prevalence, pathogenesis and response to treatment
por: Agryropoulou, Ourania, et al.
Publicado: (2018)

A case of antisynthetase syndrome
por: Mavragani, Clio P., et al.
Publicado: (2020)

Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjögren’s Syndrome-Related Lymphoma?
por: Nezos, Adrianos, et al.
Publicado: (2021)

Sjögren’s Syndrome: The Clinical Spectrum of Male Patients
por: Chatzis, Loukas, et al.
Publicado: (2020)

Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study
por: Laskari, Katerina, et al.
Publicado: (2011)

Predicting the risk for lymphoma development in Sjogren syndrome: An easy tool for clinical use
por: Fragkioudaki, Sofia, et al.
Publicado: (2016)

Update on Sjögren’s Syndrome 2018
por: Argyropoulou, Ourania D., et al.
Publicado: (2018)

Occurrence and Antigenic Specificity of Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (P-ANCA) in Systemic Autoimmune Diseases
por: Argyropoulou, Ourania D., et al.
Publicado: (2021)

Patient with ankylosing spondylitis and scleroderma renal crisis
por: Venetsanopoulou, Aliki I., et al.
Publicado: (2018)

Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren’s syndrome: prevalence, clinical and laboratory associations
por: Gravani, Fotini, et al.
Publicado: (2015)

Autoimmune rheumatic diseases: One or many diseases?
por: Moutsopoulos, Haralampos M.
Publicado: (2021)

Stress and Disease Onset in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
por: Golemati, Christina V., et al.
Publicado: (2017)

MTHFR gene variants and non-MALT lymphoma development in primary Sjogren’s syndrome
por: Fragkioudaki, Sofia, et al.
Publicado: (2017)

Anticentromere antibody positive Sjögren's Syndrome: a retrospective descriptive analysis
por: Bournia, Vasiliki-Kalliopi K, et al.
Publicado: (2010)

Liver Fibrosis in Primary Sjögren’s Syndrome
por: Androutsakos, Theodoros, et al.
Publicado: (2022)

Atherosclerosis in SLE: a potential role for serum parathormone levels
por: Giannelou, Mayra, et al.
Publicado: (2020)

TNFAIP3 F127C Coding Variation in Greek Primary Sjogren's Syndrome Patients
por: Nezos, Adrianos, et al.
Publicado: (2018)

The role of type I IFN in autoimmune and autoinflammatory diseases with CNS involvement
por: Raftopoulou, Sylvia, et al.
Publicado: (2022)

Arrhythmias and Conduction Disturbances in Autoimmune Rheumatic Disorders
por: Plastiras, Sotiris C, et al.
Publicado: (2021)

A recommended paradigm for vaccination of rheumatic disease patients with the SARS-CoV-2 vaccine
por: Moutsopoulos, Haralampos M.
Publicado: (2021)

COVID-19 Immunobiology: Lessons Learned, New Questions Arise
por: Kaklamanos, Aimilios, et al.
Publicado: (2021)

Kinetics of Mononuclear Cell Subpopulations in the Peripheral Blood of Patients with Giant Cell Arteritis During the Acute Phase of the Disease: The Role of Steroids
por: Argyropoulou, Ourania D., et al.
Publicado: (2022)

Anti-SARS-CoV-2 antibody detection in healthcare workers of two tertiary hospitals in Athens, Greece
por: Vlachoyiannopoulos, Panayiotis, et al.
Publicado: (2020)

Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients
por: Alexopoulos, Harry, et al.
Publicado: (2020)

+3179G/A Insulin-Like Growth Factor-1 Receptor Polymorphism: A Novel Susceptibility Contributor in Anti-Ro/SSA Positive Patients with Sjögren’s Syndrome: Potential Clinical and Pathogenetic Implications
por: Skarlis, Charalampos, et al.
Publicado: (2021)

Ventricular Tachycardia Has Mainly Non-Ischaemic Substrates in Patients with Autoimmune Rheumatic Diseases and a Preserved Ejection Fraction
por: Markousis-Mavrogenis, George, et al.
Publicado: (2021)

Tocilizumab improves clinical outcome in patients with active corticosteroid-resistant moderate-to-severe Graves’ orbitopathy: an observational study
por: Boutzios, Georgios, et al.
Publicado: (2023)

Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience
por: Migkos, Michalis P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tmbpc9efd587isq0m9f4j4jau8